Evidence map›Paper›PMID 40152901›Full record

ArticleeLife2025

A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice.

Lotfi Ferhat, Rabia Soussi, Maxime Masse, Grigorios Kyriatzis, Stéphane Girard, Fanny Gassiot, Nicolas Gaudin, Mathieu Laurencin, Anne Bernard, Angélique Bôle and 10 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Lotfi FerhatAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.ORCID https://orcid.org/0000-0003-2763-9472
Rabia SoussiAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Maxime MasseVECT-HORUS SAS, Faculté de Médecine, Marseille, France.
Grigorios KyriatzisAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Stéphane GirardAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Fanny GassiotVECT-HORUS SAS, Faculté de Médecine, Marseille, France.
Nicolas GaudinVECT-HORUS SAS, Faculté de Médecine, Marseille, France.
Mathieu LaurencinVECT-HORUS SAS, Faculté de Médecine, Marseille, France.
Anne BernardAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Angélique BôleAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Géraldine FerracciAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Maria SmirnovaUniversité Paris Cité, INSERM UMRS 1144, Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France.
François RomanAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Vincent DiveSIMOPRO CEA Saclay, Saclay, France.
Salvatore CisterninoUniversité Paris Cité, INSERM UMRS 1144, Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France.
Jamal TemsamaniVECT-HORUS SAS, Faculté de Médecine, Marseille, France.
Marion DavidVECT-HORUS SAS, Faculté de Médecine, Marseille, France.
Pascaline LécorchéVECT-HORUS SAS, Faculté de Médecine, Marseille, France.
Guillaume JacquotVECT-HORUS SAS, Faculté de Médecine, Marseille, France.
Michel KhrestchatiskyAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.ORCID https://orcid.org/0000-0003-4797-8332

Funding

Agence Nationale de la Recherche ANR-09-BIOT-015-01Agence Nationale de la Recherche ANR-13-RPIB-0010-01Agence Nationale de la Recherche ANR-15-CE18-0010-03
6 · The paper itself

Abstract

Preclinical and clinical studies show that mild to moderate hypothermia is neuroprotective in sudden cardiac arrest, ischemic stroke, perinatal hypoxia/ischemia, traumatic brain injury, and seizures. Induction of hypothermia largely involves physical cooling therapies, which induce several clinical complications, while some molecules have shown to be efficient in pharmacologically induced hypothermia (PIH). Neurotensin (NT), a 13 amino acid neuropeptide that regulates body temperature, interacts with various receptors to mediate its peripheral and central effects. NT induces PIH when administered intracerebrally. However, these effects are not observed if NT is administered peripherally, due to its rapid degradation and poor passage of the blood-brain barrier (BBB). We conjugated NT to peptides that bind the low-density lipoprotein receptor (LDLR) to generate 'vectorized' forms of NT with enhanced BBB permeability. We evaluated their effects in epileptic conditions following peripheral administration. One of these conjugates, VH-N412, displayed improved stability, binding potential to both the LDLR and NTSR-1, rodent/human cross-reactivity and improved brain distribution. In a mouse model of kainate (KA)-induced status epilepticus (SE), VH-N412 elicited rapid hypothermia associated with anticonvulsant effects, potent neuroprotection, and reduced hippocampal inflammation. VH-N412 also reduced sprouting of the dentate gyrus mossy fibers and preserved learning and memory skills in the treated mice. In cultured hippocampal neurons, VH-N412 displayed temperature-independent neuroprotective properties. To the best of our knowledge, this is the first report describing the successful treatment of SE with PIH. In all, our results show that vectorized NT may elicit different neuroprotection mechanisms mediated by hypothermia and/or by intrinsic neuroprotective properties.

Indexed as

AnticonvulsantsAnti-Inflammatory AgentsBlood-Brain BarrierHypothermia, InducedNeuroprotective AgentsNeurotensinStatus EpilepticusAnimalsDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLAnticonvulsantsAnti-Inflammatory AgentsNeuroprotective AgentsNeurotensinepilepsyhypothermiamouseneurosciencerat

Identifiers

PMID40152901
PMCPMC11952754

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.